SCHEMBL6834977

SCHEMBL6834977

COC1O[C@](C)(COCc2ccccc2)[C@@H](OCc2ccccc2)[C@H]1O

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BCHE P06276 3/20 0.37
PDE4D Q08499 2/20 0.36
IDO1 P14902 1/20 0.36
SSTR1 P30872 1/20 0.35
SSTR2 P30874 1/20 0.35
SSTR4 P31391 1/20 0.35
SSTR3 P32745 1/20 0.35
SSTR5 P35346 1/20 0.35
GRM2 Q14416 1/20 0.35
GRM3 Q14832 1/20 0.35
TSHR P16473 1/20 0.35
LGALS8 O00214 1/20 0.35
GJB2 P29033 1/20 0.35
TACR1 P25103 1/20 0.35
PSEN1 P49768 3/20 0.34
PSEN2 P49810 3/20 0.34
APH1B Q8WW43 3/20 0.34
NCSTN Q92542 3/20 0.34
APH1A Q96BI3 3/20 0.34
PSENEN Q9NZ42 3/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6834980 1.00 BCHE (0.37) BCHEPDE4DIDO1SSTR1SSTR2
SCHEMBL23818771 0.86 SSTR1 (0.36) BCHEPDE4DIDO1SSTR1SSTR2
SCHEMBL26136642 0.85 TSHR (0.38) BCHEPDE4DIDO1GRM2GRM3
SCHEMBL26135449 0.85 TSHR (0.38) BCHEPDE4DIDO1GRM2GRM3
SCHEMBL703496 0.82 BCHE (0.36) BCHEPDE4DIDO1SSTR1SSTR2
SCHEMBL23922552 0.81 BCHE (0.34) BCHEPDE4DIDO1SSTR1SSTR2
SCHEMBL20819176 0.81 BCHE (0.34) BCHEPDE4DIDO1SSTR1SSTR2
SCHEMBL24120239 0.81 BCHE (0.34) BCHEPDE4DIDO1SSTR1SSTR2
SCHEMBL16698760 0.81 BCHE (0.39) BCHEPDE4DIDO1SSTR1SSTR2
SCHEMBL26626297 0.81 LGALS8 (0.37) BCHEPDE4DIDO1SSTR1SSTR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040229840-A1 Nucleoside derivatives as inhibitors of RNA-dependent RNA viral polymerase ISIS PHARMACEUTICALS, INC. 2004-11-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040229840-A1 Nucleoside derivatives as inhibitors of RNA-dependent RNA viral polymerase NSUN2, NSUN3, POLRMT BCHE 2685/4885PDE4D 1080/4885IDO1 1047/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.